HERPES SIMPLEX VIRUS BASED GENE THERAPY ENHANCES THE EFFICACY OF MITOMYCIN C FOR THE TREATMENT OF HUMAN BLADDER TRANSITIONAL CELL CARCINOMA

This publication has 21 references indexed in Scilit:

• The seroepidemiology of herpes simplex virus type 1 and 2 in Europe
  Sexually Transmitted Infections, 2004
• Tissue-Specific Transcriptional Targeting of a Replication-Competent Retroviral Vector
  Journal of Virology, 2002
• Intravesical Bacillus Calmette-Guerin Reduces the Risk of Progression in Patients with Superficial Bladder Cancer: A Meta-analysis of the Published Results of Randomized Clinical Trials
  Journal of Urology, 2002
• Oncolytic viral gene therapy for prostate cancer using two attenuated, replication-competent, genetically engineered herpes simplex viruses
  The Prostate, 2002
• Oncolytic Herpesvirus Effectively Treats Murine Squamous Cell Carcinoma and Spreads by Natural Lymphatics to Treat Sites of Lymphatic Metastases
  Human Gene Therapy, 2002
• Intravesical oncolytic viral therapy using attenuated, replication‐competent, herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model
  The FASEB Journal, 2001
• Combined Therapy with Chemotherapeutic Agents and Herpes Simplex Virus Type 1 ICP34.5 Mutant (HSV-1716) in Human Non-Small Cell Lung Cancer
  Human Gene Therapy, 1999
• BLADDER CANCER CLINICAL GUIDELINES PANEL SUMMARY REPORT ON THE MANAGEMENT OF NONMUSCLE INVASIVE BLADDER CANCER (STAGES Ta, T1 AND TIS)
  Journal of Urology, 1999
• Bladder Carcinoma Cell Line KU-19-19-Derived Cytokines Support Proliferation of Growth Factor-Dependent Hematopoietic Cell Lines: Modulation by Phorbol Ester, Interferon-γ and Interleukin-1β
  Biochemical and Biophysical Research Communications, 1998
• The Effect of Intravesical Mitomycin C on Recurrence of Newly Diagnosed Superficial Bladder Cancer: A Further Report with 7 Years of Followup
  Journal of Urology, 1996